Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Construction Begins on New York City Public Health Laboratory
The New York City Economic Development Corporation began construction on the $454 million NYC Public Health Laboratory in June of 2022. Strategically sited adjacent to Harlem Hospital, the 240,000-sf building will provide the Department of Health and Mental Hygiene with sophisticated infrastructure for the detection and mitigation of infectious diseases and pathogens.
Albany College of Pharmacy and Health Sciences Acquires New Home for the Center for Biopharmaceutical Education and Training
Albany College of Pharmacy and Health Sciences has acquired an existing life sciences facility to house the Center for Biopharmaceutical Education and Training. Sited adjacent to the school's campus in Albany, New York, the 154,000-sf structure is uniquely designed for biomedical research with over 60,000 sf of BSL-2 and BSL-3 laboratory space. The five-story building will be renovated to create dedicated gene therapy labs, mammalian cell labs, teaching wet labs, biopharmaceutical pilot plants, and fermentation and downstream processing facilities.
North Carolina State University Dedicates Plant Sciences Building
North Carolina State University dedicated the $160.2 million Plant Sciences Building in Raleigh in April of 2022. Designed by Flad Architects, the 185,000-sf facility enables academic, government, and industry researchers to develop innovative solutions for global agricultural challenges.
Southern Research Constructs Biotechnology Center
Southern Research will begin construction in mid-2022 on an $84 million biotechnology center in Birmingham, Ala. Providing crucial biocontainment capacity for the study of infectious diseases, the 80,000-sf building will enhance pandemic preparedness efforts with BSL-3 laboratories spanning 7,500 sf. The five-level project will also include structural biology labs, high-throughput screening facilities, and a STEM education center.
Amgen Breaks Ground on Biomanufacturing Center
Amgen broke ground in March of 2022 on a $550 million biomanufacturing center in Holly Springs, N.C. Accommodating the company's FleXBatch platform, the project will integrate traditional methods for drug substance production with single-use bioprocessing technologies to create a hybrid facility with unrivaled operational efficiencies. The next-generation plant will manufacture advanced therapeutics for the treatment of cardiovascular disease, cancer, osteoporosis, inflammation, and other conditions.